• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强直性脊柱炎患者血浆肿瘤坏死因子-α、胰岛素样生长因子-1、骨代谢生化标志物、炎症/疾病活动标志物与临床表现之间的相关性

Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis.

作者信息

Lange U, Teichmann J, Stracke H

机构信息

Kerckhoff Clinic and Foundation, Department of Rheumatology, University Giessen, Ludwig Str. 37-39, D-61231 Bad Nauheim, Germany.

出版信息

Eur J Med Res. 2000 Dec 29;5(12):507-11.

PMID:11147993
Abstract

In patients with established ankylosing spondylitis (AS) and a healthy control group, plasma levels of IGF-1 and TNF-alpha as well as possible connections with biochemical markers of the bone metabolism, humoral inflammatory activity (ESR, CRP), clinical manifestations, and an established clinical activity score (Bath Ankylosing Spondylitis Activity Index = BASDAI) were examined. In AS-patients (men and women) significantly increased TNF-alpha levels were found. Moreover, patients with enthesopathy showed a significantly more frequent increase of CRP and TNF-alpha levels besides an increased urinary pyridinium cross-link excretion. In addition, a significant positive correlation between TNF-alpha, CRP, BASDAI, and urinary pyridinium cross-link excretion was proved, besides a significant negative correlation of IGF-I to urinary pyridinium cross-links and TNF-alpha levels. Summing up, it may be said that TNF-alpha seems to be a reliable surrogate marker in enthesitis. This was proved so far for IgA and endothelium stimulating angiogenic factor only. Besides, the present results argue against a stimulation of osteogenesis. The catabolic situation under high TNF-alpha and low IGF-1 levels may play an important role in the pathogenesis of osteoporosis in AS.

摘要

在确诊的强直性脊柱炎(AS)患者和健康对照组中,检测了血浆中胰岛素样生长因子-1(IGF-1)和肿瘤坏死因子-α(TNF-α)的水平,以及它们与骨代谢生化标志物、体液炎症活性(红细胞沉降率、C反应蛋白)、临床表现和既定临床活动评分(巴斯强直性脊柱炎活动指数=BASDAI)之间的可能联系。在AS患者(男性和女性)中,发现TNF-α水平显著升高。此外,附着点病患者除尿吡啶交联排泄增加外,CRP和TNF-α水平升高的频率也显著更高。此外,除了IGF-I与尿吡啶交联和TNF-α水平呈显著负相关外,还证实了TNF-α、CRP、BASDAI和尿吡啶交联排泄之间存在显著正相关。总之,可以说TNF-α似乎是附着点炎中一个可靠的替代标志物。到目前为止,仅对IgA和内皮刺激血管生成因子证明了这一点。此外,目前的结果反对骨生成的刺激。高TNF-α和低IGF-1水平下的分解代谢状态可能在AS骨质疏松症的发病机制中起重要作用。

相似文献

1
Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis.强直性脊柱炎患者血浆肿瘤坏死因子-α、胰岛素样生长因子-1、骨代谢生化标志物、炎症/疾病活动标志物与临床表现之间的相关性
Eur J Med Res. 2000 Dec 29;5(12):507-11.
2
Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.接受依那西普治疗的强直性脊柱炎患者临床反应及骨生化标志物的变化
J Rheumatol. 2007 Aug;34(8):1753-9. Epub 2007 Jun 15.
3
Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis.骨桥蛋白可能参与强直性脊柱炎的骨重塑而非炎症反应。
Rheumatology (Oxford). 2008 Dec;47(12):1775-9. doi: 10.1093/rheumatology/ken385. Epub 2008 Oct 14.
4
[Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].[两种抗肿瘤坏死因子-α抑制剂英夫利昔单抗和依那西普对强直性脊柱炎患者血清基质金属蛋白酶3表达水平的影响]
Zhonghua Yi Xue Za Zhi. 2006 Sep 19;86(35):2451-4.
5
Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis.血清瘦素水平与强直性脊柱炎患者的白细胞介素-6水平及疾病活动度相关。
Scand J Rheumatol. 2007 Mar-Apr;36(2):101-6. doi: 10.1080/03009740600991760.
6
Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.在无临床明显心血管疾病的强直性脊柱炎患者中,动脉僵硬度增加或内膜中层厚度增加的趋势。
Rheumatology (Oxford). 2008 Aug;47(8):1203-7. doi: 10.1093/rheumatology/ken198. Epub 2008 Jun 4.
7
[Adaption and validation of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for use in Germany].[用于德国的巴斯强直性脊柱炎疾病活动指数(BASDAI)的改编与验证]
Z Rheumatol. 2003 Jun;62(3):264-73. doi: 10.1007/s00393-003-0522-y.
8
Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations.巴斯强直性脊柱炎疾病活动指数与该指数的一个修订版本在评估无外周表现的强直性脊柱炎患者疾病活动度方面的比较。
Ann Rheum Dis. 2009 Nov;68(11):1701-7. doi: 10.1136/ard.2008.099226. Epub 2008 Nov 24.
9
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.ASDAS,一种在强直性脊柱炎患者中经ASAS认可的具有高度鉴别力的疾病活动评分。
Ann Rheum Dis. 2009 Dec;68(12):1811-8. doi: 10.1136/ard.2008.100826. Epub 2008 Dec 5.
10
The platelet functions in patients with ankylosing spondylitis: anti-TNF-alpha therapy decreases the mean platelet volume and platelet mass.强直性脊柱炎患者的血小板功能:抗 TNF-α 治疗可降低平均血小板体积和血小板质量。
Platelets. 2010;21(2):126-31. doi: 10.3109/09537100903470306.

引用本文的文献

1
Elevated tumor necrosis factor alpha and vascular endothelial growth factor in intermediate age-related macular degeneration and geographic atrophy.中年年龄相关性黄斑变性和地图样萎缩中肿瘤坏死因子α及血管内皮生长因子水平升高。
Front Ophthalmol (Lausanne). 2024 Mar 26;4:1356957. doi: 10.3389/fopht.2024.1356957. eCollection 2024.
2
Immune mechanism of low bone mineral density caused by ankylosing spondylitis based on bioinformatics and machine learning.基于生物信息学和机器学习的强直性脊柱炎所致低骨密度的免疫机制
Front Genet. 2022 Nov 18;13:1054035. doi: 10.3389/fgene.2022.1054035. eCollection 2022.
3
Uveitis increases the risk of stroke among patients with ankylosing spondylitis: A nationwide population-based longitudinal study.
葡萄膜炎会增加强直性脊柱炎患者中风的风险:一项基于全国人口的纵向研究。
Front Immunol. 2022 Oct 6;13:959848. doi: 10.3389/fimmu.2022.959848. eCollection 2022.
4
Oliver's Multitarget Mechanism for Treatment of Ankylosing Spondylitis: A Study Based on Network Pharmacology and Molecular Docking.奥利弗治疗强直性脊柱炎的多靶点机制:一项基于网络药理学和分子对接的研究
Evid Based Complement Alternat Med. 2022 Oct 11;2022:3699146. doi: 10.1155/2022/3699146. eCollection 2022.
5
[Hyperactivation of PI3K/AKT/mTOR signal pathway impairs TNF-α-induced autophagy in mesenchymal stem cells from patients with ankylosing spondylitis].[PI3K/AKT/mTOR信号通路的过度激活损害强直性脊柱炎患者间充质干细胞中TNF-α诱导的自噬]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Feb 20;42(2):272-277. doi: 10.12122/j.issn.1673-4254.2022.02.15.
6
Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea.戈利木单抗在风湿性疾病中的真实世界安全性和有效性:韩国的上市后监测
Rheumatol Ther. 2021 Sep;8(3):1393-1404. doi: 10.1007/s40744-021-00352-6. Epub 2021 Jul 29.
7
Study of vertebral fracture and Scanographic Bone Attenuation Coefficient in rheumatoid arthritis and ankylosing spondylitis vs. controls.类风湿关节炎和强直性脊柱炎与对照组的脊柱骨折和扫描骨衰减系数研究。
Sci Rep. 2019 Sep 16;9(1):13323. doi: 10.1038/s41598-019-49712-x.
8
Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy?脊柱关节炎患者葡萄膜炎治疗的进展——是时候采用生物疗法了吗?
Rom J Ophthalmol. 2018 Apr-Jun;62(2):114-122.
9
The Protective Effect of Extract against Ankylosing Spondylitis in Mouse Models.提取物对小鼠强直性脊柱炎模型的保护作用。
Biomed Res Int. 2017;2017:8206281. doi: 10.1155/2017/8206281. Epub 2017 Feb 2.
10
TNF- Induced the Enhanced Apoptosis of Mesenchymal Stem Cells in Ankylosing Spondylitis by Overexpressing TRAIL-R2.肿瘤坏死因子通过过表达肿瘤坏死因子相关凋亡诱导配体受体2(TRAIL-R2)诱导强直性脊柱炎中间充质干细胞凋亡增强。
Stem Cells Int. 2017;2017:4521324. doi: 10.1155/2017/4521324. Epub 2017 Jan 15.